Dr. Mark Pines
Dr. Pines specializes in connective tissue research and tissue response to injury or neoplasia, with a particular interest in the signaling role of collagen and matrix proteins. He was responsible for the discovery of the mechanism of action and clinical utility of Halofuginone. Dr. Pines has been a visiting scientist at the U.S. NIH Metabolic Disease Branch and Harvard Medical School. He was named the Volcani Institute's "Researcher of the Year" in 1997 and is the primary or co-author of more than 90 publications. Dr. Pines has received a series of grants from the Cap Cure foundation to study the potential of Halofuginone to treat prostate cancer.
The most recent publications
Pines.pdf 
